Skip to main content

Structure-Activity Relations for Neurotransmitter Receptor Agonists and Antagonists

  • Chapter
Principles of Receptor Research

Part of the book series: Handbook of Psychopharmacology ((SIBN,volume 2))

  • 58 Accesses

Abstract

Until fairly recently, the only way of discovering anything about the nature of postsynaptic receptors for neurotransmitters was the time-honored method of studying the structure-activity relationships of agonists and antagonists. This information was usually incidental to the main practical preoccupation of finding compounds that were pharmacologically more active and specific. The nature of the information obtainable about receptors by this method is, of course, limited. One may show, for example, that in a particular drug certain chemical groups are essential for activity. Depending on the nature of these groups, it is possible to hypothesize binding via ionic or hydrogen bonds and van der Waals or hydrophobic interactions. However, the nature of the receptor components through which these interactions occur is in most cases totally unknown. There is also the problem that unless one works with conformationally rigid moelcules the actual shape of the drug on interaction with the receptor is uncertain. In recent years, more direct attempts have been made to learn something of the chemical nature of various receptors by actual isolation of the macromolecules thought to comprise the receptor material. An extensive review of earlier work in this area using a variety of reversible and irreversible agonists and antagonists has been published (Ehrenpreis et al., 1969). More recent studies are dealt with elsewhere in this series (Hollenberg and Cuatrecasas, Chap. 5, this volume; Changeux, Chap. 7, Vol. 6; Snyder, Chap. 6, Vol. 5).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adamson, D. W., Barrett, P. A., Billinghurst, J. W., Green, A. F., Jones, T.S. G.: 1951. Geometrical Isomers in a Series of Antihistamines, Nature 168: 204–205.

    Article  PubMed  Google Scholar 

  • Ahlquist, R. P.: 1948. A study of adrenotropic receptors, Am. J. Physiol. 153: 586–600.

    PubMed  Google Scholar 

  • Ahlquist, R. P.: 1968. Agents which block adrenergic A-receptors, in: Annual Review of Pharamacology, Vol 8 ( H. W. Elliott, ed.), pp. 259–272, Annual Reviews, Inc., Palo Alto, Calif.

    Google Scholar 

  • Ainsworth, C.: 1958. Substituted β-aminoethylindazoles, J. Am. Chem. Soc. 80: 965–967.

    Article  Google Scholar 

  • Aizenshtat, Z., Klein, E., Weiler-Feilchenfeld, H., Bergmann, E. D.: 1972. Conformational studies on xanthene, thioxanthene and acridan, Israel J. Chem. 10: 753–763.

    Google Scholar 

  • Anden, N. E., Roos, B. E., Werdinius, B.: 1964. Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum, Life Sci. 3: 149–158.

    Article  Google Scholar 

  • Anden, N. E., Rubenson, A., Fuxe, K., Hokfelt, T.: 1967. Evidence for dopamine receptor stimulation by apomorphine, J. Pharm. Pharmacol. 19: 627–629.

    Article  PubMed  Google Scholar 

  • Anden, N. E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: 1970. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics, Eur. J. Pharmacol. 11: 303–314.

    Article  PubMed  Google Scholar 

  • Ariens, E. J.: 1963. in: First International Pharmacological Meeting Stockholm 1961, Vol. 7, p. 247, Macmillan, New York.

    Google Scholar 

  • Ariens, E. J.: 1967. The structure-activity relationships of A-adrenergic drugs and A-adrenergic blocking drugs, Ann. N.Y. Acad. Sci. 139: 606–631.

    Article  PubMed  Google Scholar 

  • Ariens, E. J.: 1971. A general introduction to the field of drug design, in: Drug Design, Vol. 1 ( E. J. Ariens, ed.), pp. 1–270, Academic Press, New York.

    Google Scholar 

  • Ariens, E. J., Simonis, A. M.: 1964. A molecular basis for drug action, J. Pharm. Pharmacol. 16: 137–157.

    Article  Google Scholar 

  • Aroney, M. J., Hoskins, G. M., Lefevre, R. J. W.: 1968. Molecular polarisability: The conformations as solutes of phenothiazine and of N-methyl and N-phenylphenothiazine, J. Chem. Soc. (B) 1968: 1206–1208.

    Google Scholar 

  • Ash, A. S. F., Schild, H. O.: 1966. Receptors mediating some actions of histamine, Brit. J. Pharmacol. 27: 427–439.

    PubMed  Google Scholar 

  • Bachrach, W. H.: 1958. Anticholinergic drugs: Survey of the literature and some experimental observations, Am. J. Digest. Dis. 3: 743–799.

    Article  PubMed  Google Scholar 

  • Baker, R. W., Chothia, C. H., Pauling, P., Petcher, T. J.: 1971. Structure and activity of muscarinic stimulants, Nature 230: 439–445.

    Article  PubMed  Google Scholar 

  • Banister, J., Whittaker, V. P.: 1951. Pharmacological activity of the carbon analogue of acetylcholine, Nature 167: 605–606.

    Article  PubMed  Google Scholar 

  • Barger, G., Dale, H. H.: 1910. Chemical structure and sympathomimetic action of amines, J. Physiol. 41: 19–59.

    PubMed  Google Scholar 

  • Barlow, R. B.: 1964. Introduction to Chemical Pharamacology, 2nd ed., pp. 344–377, Wiley, New York.

    Google Scholar 

  • Barlow, R. B., Kahn, I.: 1959a. Actions of some analogues of tryptamine on the isolated rat uterus and on the isolated rat fundus strip preparations, Brit. J. Pharmacol. 14: 99–107.

    PubMed  Google Scholar 

  • Barlow, R. B., Kahn, I.: 1959b. Actions of some analogues of 5-hydroxytryptamine on the isolated rat uterus and the rat fundus strip preparations, Brit. J. Pharmacol. 14: 265–272.

    PubMed  Google Scholar 

  • Barlow, R. B., Scott, K. A., Stephenson, R. P.: 1963. An attempt to study the effects of chemical structure on the affinity and efficacy of compounds related to acetylcholine, Brit. J. Pharmacol. 21: 509–522.

    PubMed  Google Scholar 

  • Barrett, A. M.: 1972. Design of α-blocking drugs, in: Drug Design, Vol. III. ( E. J. Ariens, ed.), pp. 205–228, Academic Press, New York.

    Google Scholar 

  • Beckett, A. H., Harper, N. J., Clitherow, J. W., Lesser, E.: 1961. Muscarinic receptors, Nature 189: 671–673.

    Article  PubMed  Google Scholar 

  • Beers, W. H., Reich, E.: 1970. Structure and activity of acetylcholine, Nature 228: 917–922.

    Article  PubMed  Google Scholar 

  • Bell, C., Lang, W. J.: 1973. Neural dopaminergic vasodilator control in the kidney, Nature 246: 27–29.

    Google Scholar 

  • Belleau, B.: 1965. In: Isotopes in Pharmacology (L. Roth, ed.), p. 469, University of Chicago Press, Chicago.

    Google Scholar 

  • Belleau, B.: 1967. Stereochemistry of adrenergic receptors: Newer concepts on the molecular mechanism of action of catecholamines and antiadrenergic drugs at the receptor level, Ann. N.Y. Acad. Sci. 139: 580–605.

    Article  PubMed  Google Scholar 

  • Bergin, R., Carlstrom, D.: 1968. The crystal structure of dopamine hydrochloride, Acta Crystallog. B24: 1506–1510.

    Article  Google Scholar 

  • Berridge, M. J.: 1972. The mode of action of 5-hydroxytryptamine, J. Exp. Biol. 56: 311–321.

    PubMed  Google Scholar 

  • Berridge, M. J., Patel, N. E.: 1968. Insect salivary glands: Stimulation of fluid secretion by 5-hydroxytryptamine and adenosine 3’,5’-monophosphate, Science 162: 462–463.

    Article  PubMed  Google Scholar 

  • Bertaccini, G., Zamboni, P.: 1961. The relative potency of 5-hydroxytryptamine-like substances, Arch. Int. Pharmacodyn. 133: 138–156.

    PubMed  Google Scholar 

  • Beveridge, D. L., Radna, R. J.: 1971. A quantum theoretical study of the molecular electronic structure of acetylcholine, J. Am. Chem. Soc. 93: 3759–3764.

    Article  PubMed  Google Scholar 

  • Biscoe, T. J., Curtis, D. R., Ryall, R. W.: 1966. An investigation of catecholamine receptors of spinal interneurones, Int. J. Neuropharmacol. 5: 429–434.

    Article  PubMed  Google Scholar 

  • Black, J. M., Duncan, W. A. M., Shanks, R. G.: 1965. Comparison of some properties of pronethalol and propranolol, Brit. J. Pharmacol. 25: 577–591.

    PubMed  Google Scholar 

  • Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R., Parsons, E. M.: 1972. Definition and antagonism of histamine H2-receptors, Nature 236: 385–390.

    Article  PubMed  Google Scholar 

  • Blinks, J. R.: 1967. Evaluation of the cardiac effects of several α-adrenergic blocking agents, Ann. N.Y. Acad. Sci. 139: 673–685.

    Article  PubMed  Google Scholar 

  • Bloom, B. M., Goldman, I. M.: 1966. The nature of catecholamine-adenine mononucleotide interactions in adrenergic mechanisms, in: Advances in Drug Research, Vol. 3 ( N. J. Harper, A. B. Simmonds, eds.), pp. 121–169, Academic Press, London.

    Google Scholar 

  • Bloom, F. E., Costa, E., Salmoiraghi, G. C.: 1964. Analysis of individual rabbit olfactory bulb neuron responses to the microelectrophoresis of acetylcholine, norepinephrine and serotonin synergists and antagonists, J. Pharmacol. Exp. Ther. 146: 16–23.

    PubMed  Google Scholar 

  • Boakes, R. J., Bradley, P. B., Brookes, N., Candy, J. M., Wolstencroft, J. H.: 1971. Actions of noradrenaline, other sympathomimetic amines and antagonists on neurones in the brain stem of the cat, Brit. J. Pharmacol. 41: 462–479.

    Google Scholar 

  • Born, G. V. R.: 1971. In: Effects of Drugs on Cellular Control Mechanisms (B. R. Rabin, R. B. Freedman, eds.), pp. 237–257, Macmillan, London.

    Google Scholar 

  • Bovet, D.: 1950. Introduction to antihistamine agents and antergan derivatives, Ann. N.Y. Acad. Sci. 50: 1089–1126.

    Article  PubMed  Google Scholar 

  • Bovet, D., Bovet-Nitti, F.: 1948. In: Medicaments du Systeme Nerveux Vegetatif, pp. 222–237, Karger, Basel.

    Google Scholar 

  • Bovet, D., Bovet-Nitti, F., Marini-Bettolo, G. B.: (eds.), 1959. Curare and Curare-like Agents, Elsevier, Amsterdam.

    Google Scholar 

  • Brotzu, G.: 1970. Inhibition by chlorpromazine of the effects of dopamine on the dog kidney, J. Pharm. Pharmacol. 22: 664–667.

    Article  PubMed  Google Scholar 

  • Brown, J. H., Makman, M. H.: 1972. Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine 3’,5’-cyclic monphosphate formation in intact retina, Proc. Natl. Acad. Sci. 69: 539–543.

    Article  PubMed  Google Scholar 

  • Brown, J. H., Makman, M. H.: 1973. Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina, J. Neurochem. 21: 477–479.

    Article  PubMed  Google Scholar 

  • Burgen, A. S. V.: 1965. The role of ionic interaction at the muscarinic receptor, Brit. J. Pharmacol. 25: 4–17.

    PubMed  Google Scholar 

  • Burgen, A, S. V., Hiley, C. R., Young, J. M.: 1974a. The binding of 3H- propylbenzilylcholine mustard by longitudinal muscle strips from guinea-pig small intestine, Brit. J. Pharmacol. 50: 145–151.

    Google Scholar 

  • Burgen, A. S. V., Hiley, C. R., Young, J. M.: 1974b. The properties of muscarinic receptors in mammalian cerebral cortex, Brit. J. Pharmacol., 51: 279–285.

    Google Scholar 

  • Burger, A., Bernabe, M., Collins, P. W.: 1970. (4-Imidazolyl) Cyclopropylamine, J. Med. Chem. 13: 33–35.

    Google Scholar 

  • Burks, T. F., Long, J. P., Darko, L. L., Cannon, J. G.: 1965. Evaluation of n-methoxy substitution in cholinergic agents, Fed. Proc. 24: 611.

    Google Scholar 

  • Burns, J. J., Colville, K. I., Lindsay, L. A., Salvador, R. A.: 1964. Blockade of some metabolic effects of catecholamines by N-isopropyl methoxamine (B. W. 61–43), J. Pharmacol. Exp. Ther. 144: 163–171.

    PubMed  Google Scholar 

  • Burns, T. W., Langley, P. E., Robison, G. A.: 1971. Adrenergic receptors and cyclic AMP: Regulation of human adipose tissue lipolysis, Ann. N.Y. Acad. Sci. 185: 115–128.

    Article  PubMed  Google Scholar 

  • Cameron, W. M., Tainter, M. L.: 1936. Comparative actions of sympathomimetic compounds: Bronchiodilator actions in bronchial spasms induced by histamine, J. Pharmacol. Exp. Ther. 57: 152–169.

    Google Scholar 

  • Campaigne, E., Knapp, D. R., Neiss, E. S., Bosin, T. R.: 1970. Biologically active benzothiophene derivatives, in: Advances in Drug Research, Vol. 5 ( N. J. Harper, A. B. Simmonds, eds.), pp. 1–54, Academic Press, London.

    Google Scholar 

  • Canepa, F. G., Pauling, P. J., Sorum, H.: 1966. Structure of acetylcholine and other substrates of cholinergic systems, Nature 210: 907–909.

    Article  PubMed  Google Scholar 

  • Cannon, J. G., Long, J. P.: 1967. Postganglionic parasympathetic depressants, in: Drugs Affecting the Peripheral Nervous System ( A. Burger, ed.), pp. 133–148, Dekker, New York.

    Google Scholar 

  • Carlsson, A., Lindqvist, M.: 1963. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain, Acta Pharmacol. Toxicol. 20: 140–144.

    Article  Google Scholar 

  • Carlsson, A., Fuxe, K., Hamberger, B., Lindqvist, M.: 1966. Biochemical and histochem- ical studies of the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons, Acta Physiol. Scand. 67: 481–497.

    Article  PubMed  Google Scholar 

  • Carlstrom, D., Bergin, R.: 1967. The crystal structure of noradrenaline hydrochloride, Acta Crystallog. 23: 313–319.

    Article  Google Scholar 

  • Carlstrom, D., Bergin, R., Falkenberg, G.: 1973. Molecular characteristics of biogenic monoamines and their analogs, Quart. Rev. Biophys. 6: 257–310.

    Article  Google Scholar 

  • Carr, L. A., Moore, K. E.: 1970. Effects of amphetamine on the contents of norepinephrine and its metabolites in the effluent of perfused cerebral ventricles of the cat, Biochem. Pharmacol. 19: 2361–2374.

    Article  PubMed  Google Scholar 

  • Casy, A. F., Ison, R. R., Ham, N. S.: 1970. The conformation of histamine in solution: Nuclear magnetic resonance study, Chem. Commun. 1970: 1343–1344.

    Google Scholar 

  • Chang, H. C., Gaddum, J. H.: 1933. Choline esters in tissue extracts, J. Physiol. 79: 255–285.

    PubMed  Google Scholar 

  • Chothia, C.: 1970a. Interaction of acetylcholine with different cholinergic nerve receptors, Nature 225: 36–38.

    Article  PubMed  Google Scholar 

  • Chothia, C.: 1970b. Structure-activity relationships of some muscarinic agonists: A reply to Shefter and Triggle, Nature 227: 1355–1356.

    Article  PubMed  Google Scholar 

  • Chothia, C., Pauling, I.: 1968. Conformations of acetylcholine, Nature 219: 1156–1157.

    Article  PubMed  Google Scholar 

  • Chothia, C., Pauling, P.: 1970. The conformation of cholinergic molecules at nicotinic nerve receptors, Proc. Natl. Acad. Sci. 65: 477–482.

    Article  PubMed  Google Scholar 

  • Cole, B., Robison, G. A., Hartmann, R. C.: 1971. Studies on the Role of Cyclic AMP in Platelet Function, Ann. N.Y. Acad. Sci. 185: 477–487.

    Article  PubMed  Google Scholar 

  • Colhoun, E. H.: 1963. Synthesis of 5-hydroxytryptamine in the American cockroach, Experientia 19: 9–10.

    Article  PubMed  Google Scholar 

  • Corrodi, H., Persson, H., Carlsson, A., Roberts, J.: 1963. A new series of substances which block the adrenergic a-receptors, J. Med. Chem. 6: 751–755.

    Article  PubMed  Google Scholar 

  • Coyle, J. T., Snyder, S. H.: 1969. Antiparkinsonian drugs: Inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action, Science 166: 899–901.

    Article  PubMed  Google Scholar 

  • Cuello, A. C., Horn, A. S., Mackay, A. V. P., Iversen, L. L.: 1973. Catecholamines in the median eminence: New evidence for a major noradrenergic input, Nature 243: 465–467.

    Article  PubMed  Google Scholar 

  • Culvenor, C. C. J., Ham, N. S.: 1966. The proton magnetic resonance spectrum and conformation of acetylcholine, Chem. Commun. 1966: 537–539.

    Google Scholar 

  • Cushley, R. J., Mautner, H. G.: 1970. N.M.R. studies on the conformation of acetylcholine isologues, Tetrahedron 26: 2151–2159.

    Article  Google Scholar 

  • Cuthbert, A. W., Young, J. M.: 1973. The number of muscarinic receptors in chick amnion muscle, Brit. J. Pharmacol. 49: 498–505.

    Google Scholar 

  • Dale, H. H.: 1906. On some physiological actions of ergot, J. Physiol. 34: 163–206.

    PubMed  Google Scholar 

  • Dale, H. H.: 1953. Adventures in Physiology, Pergamon Press, London.

    Google Scholar 

  • Dalgliesh, C. E., Toh, C. C., Work, T. S.: 1953. Fractionation of the smooth muscle stimulants present in extracts of gastro-intestinal tract: Identification of 5-hydroxytryptamine and its distinction from substance P, J. Physiol. 120: 298–310.

    PubMed  Google Scholar 

  • Daprada, M., Pletscher, A.: 1966. Acceleration of cerebral dopamine turnover by chlorpromazine, Experientia 22: 465–466.

    Article  Google Scholar 

  • Dollery, C. T., Paterson, J. W., Conolly, M. E.: 1969. Clinical pharmacology of beta receptor blocking drugs, Clin. Pharmacol. Ther. 10: 765–799.

    Google Scholar 

  • Dorignac-Calas, M. R., Marsau, P.: 1972. Structure cristalline du chlorhydrate de chloro-3 (dimethylamino-3’propyl)-10-phenothiazine, Comp. Rend. Acad. Sei. Paris 274: 1806–1809.

    Google Scholar 

  • Dunitz, J. D., Eser, H., Strickler, P.: 1964. Die Konfiguration des physiologisch Wirksamen 2-Chloro-9-(w-dimethylaminopropyliden)-thioxanthens, Helv. Chim. Acta 47: 1897–1902.

    Article  Google Scholar 

  • Ehrenpreis, S., Fleisch, J. H., Mittag, T. W.: 1969. Approaches to the molecular nature of pharmacological receptors, Pharmacol. Rev. 21: 131–181.

    PubMed  Google Scholar 

  • Ellenbroek, B. W. J., van Rossum, J. N.: 1960. Absolute configuration and parasympathomimetic activity—Chemistry and pharmacology of acetyl-γ-methyl choline, Arch. Int. Pharmacodyn. 125: 216–220.

    PubMed  Google Scholar 

  • Erlenmeyer, H., Lobeck, H.: 1937. Darstellung und Eigenschaften des Acetyl-β-cholin, Helv. Chim. Acta 20: 142–150.

    Article  Google Scholar 

  • Ernst, A. M.: 1967. Mode of action of apomorphine and D-amphetamine for gnawing compulsion in rats, Psychopharmacologia 10: 316–323.

    Article  PubMed  Google Scholar 

  • Erspamer, V.: 1940. Pharmakologische Studien über Enteramin. I, Naunyn-Schmiedberg’s Arch. Exp. Pathol. Pharmakol. 196: 343–365.

    Article  Google Scholar 

  • Erspamer, V.: 1954. II sistema cellulare enterocromaffine e L’enteramina (5-idrossitriptamina), Rend. Sei. Farm. 1: 1–193.

    Google Scholar 

  • Erspamer, V.: 1966. Bioassay of indoleaklyamines, in: 5-Hydroxytryptamine and Related Indolealkylamines (O. Elchler, A. Farah, eds.), pp. 132–181, Vol. 19 of Handbook of Experimental Pharmacology, Springer, Berlin.

    Google Scholar 

  • Eugster, C. H.: 1959. Synthese and pharmakologische Eigenschaften des Desmethylmus- carones und der stereoisomeren Desmethylmuscarine Die Basen starken der isomeren Normuscarine, Helv. Chim. Acta 42: 1177–1189.

    Article  Google Scholar 

  • Everett, A. J., Laue, L. A., Wilkinson, S.: 1970. Revision of the structures of (+)-tubocurarine chloride and (+)-chondrocurine, Chem. Commun. 1970: 1020–1021.

    Google Scholar 

  • Fellman, J. H., Fujita, T. S., Belber, C. J.: 1962. β-Dihydro-δ-Hydroxytryptamine, Biochem. Pharmacol. 11: 557–561.

    Google Scholar 

  • Fewtrell, C. M. S., Rang, H. P.: 1973. Labelling cholinergic receptors in smooth muscle, in: Drug Receptors ( H. P. Rang, ed.), pp. 211–224, Macmillan, London.

    Google Scholar 

  • Freyhan, F. A.: 1961. In: Extrapyramidal System and Neuroleptics (J. M. Bordeleau, ed.), pp. 483–486, Editions Psychiatriques, Montreal.

    Google Scholar 

  • Friedman, H. L.: 1967. Postganglionic parasympathetic stimulants, in: Drugs Affecting the Peripheral Nervous System, ( A. Burger, ed.), pp. 79–131, Dekker, New York.

    Google Scholar 

  • Furchgott, R. F.: 1972. The classification of adrenoceptors (adrenergic receptors): An evaluation from the standpoint of receptor theory, in: Catecholamines, (H. Blaschko, E. Muscholl, eds.), pp. 283–335, Vol. 33 of Handbook of Experimental Pharmacology, Springer, Berlin.

    Google Scholar 

  • Fuxe, K.: 1965. Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monamine nerve terminals in the central nervous system, Acta Physiol. Scand. 64:37–85 (Suppl. 247 ).

    Google Scholar 

  • Gaddum, J. H., Hameed, K. A.: 1954. Drugs which antagonize δ-hydroxytryptamine, Brit. J. Pharmacol. 9: 240–248.

    PubMed  Google Scholar 

  • Gaddum, J. H., Paasonen, M. K.: 1955. The use of some molluscan hearts for the estimation of 5-hydroxytryptamine, Brit. J. Pharmacol. 10: 474–483.

    PubMed  Google Scholar 

  • Gaddum, J. H., Picarelli, Z.: 1957. Two kinds of tryptamine receptors, Brit. J. Pharmacol. 12: 323–328.

    PubMed  Google Scholar 

  • Garattini, S., Valzelli, L.: 1965. Serotonin, Elsevier, Amsterdam.

    Google Scholar 

  • Gearien, J. E.: 1970. Cholinergics and anticholinesterases, in: Medicinal Chemistry, Part II, 3rd ed. ( A. Burger, ed.), pp. 1296–1313, Wiley-Interscience, New York.

    Google Scholar 

  • Geiger, W. B., Alpers, H.: 1964. Properties of an acetylated derivative of trimethylamine oxide, Arch. Int. Pharmacodyn. 148: 352–358.

    PubMed  Google Scholar 

  • Giesecke, J.: 1973. The crystal and molecular structure of apomorphine hydrochloride hydrate, Acta Crystallog. B29: 1785–1791.

    Article  Google Scholar 

  • Gill, E. W., Rang, H. P.: 1966. An alkylating derivative of benzilycholine with specificand long-lasting parasympatholytic activity, Mol. Pharmacol. 2: 284–297.

    PubMed  Google Scholar 

  • Glowinski, J.: 1970. Effects of amphetamine on various aspects of catecholamine metabolism in the central nervous system of the rat, in: Amphetamines and Related Compounds ( E. Costa, S. Garattini, eds.), pp. 301–316, Raven Press, New York.

    Google Scholar 

  • Goldberg, L. I., Sonneville, P. F., Mcnay, J. L.: 1968. An investigation of the structural requirements for dopamine-like renal vasodilation: Phenylethylamines and apomorphine, J. Pharmacol. Exp. Ther. 163: 188–197.

    PubMed  Google Scholar 

  • Goodman, L. S., Gilman, A.: 1970. The Pharmacological Basis of Therapeutics, 4th ed., Macmillan, New York.

    Google Scholar 

  • Gordon, M.: 1967. Phenothiazines, in: Psychopharmacological Agents, Vol. 11, ( M. Gordon, ed.), pp. 1–198, Academic Press, New York.

    Google Scholar 

  • Green, A. L.: 1967. Activity correlations and the mode of action of aminoalkylphenothiazine tranquillizers, J. Pharm. Pharmacol. 19: 207–208.

    Article  PubMed  Google Scholar 

  • Greenberg, M. J.: 1960. Structure-activity relationship of tryptamine analogues on the heart of Venus mercenaria, Brit. J. Pharmacol. 15: 375–388.

    PubMed  Google Scholar 

  • Gunn, J. A., Gurd, M. R.: 1940. The action of some amines related to adrenaline: Cyclohexylalkylamines, J. Physiol. 97: 453–470.

    PubMed  Google Scholar 

  • Gyermek, L.: 1961. β-Hydroxy tryptamine antagonists, Pharmacol. Rev. 13: 399–439.

    Google Scholar 

  • Gyermek, L.: 1966. Drugs which antagonize 5-hydroxytryptamine and related indolealkylamines, in: δ-Hydroxytryptamine and Related Indolealkylamines (O. Eichler, A. Farah, eds.), pp. 471–528, Vol. 19 of Handbook of Experimental Pharmacology, Springer, Berlin.

    Google Scholar 

  • Gyermek, L., Bindler, E.: 1962. Action of indole alkylamines and amidines on the inferior mesenteric ganglion of the cat, J. Pharmacol. Exp. Ther. 138: 159–164.

    PubMed  Google Scholar 

  • Gyermek, L., Nador, K.: 1957. The pharmacology of tropane compounds in relation to their steric structure, J. Pharm. Pharmacol. 9: 209–229.

    Article  PubMed  Google Scholar 

  • Gyermek, L., Unna, K. R.: 1958. Relation of structure of synthetic muscarines and muscarones to their pharmacological action, Proc. Soc. Exp. Biol. Med. 98: 882–885.

    PubMed  Google Scholar 

  • Harms, A. F., Nauta, W. T.: 1960. The effects of alkyl substitution on drugs. 1. Substituted dimethylaminoethyl benzhydryl ethers, J. Med. Pharm. Chem. 2: 57–77.

    Article  PubMed  Google Scholar 

  • Harrison, D. C.: 1971. Circulatory Effects and Clinical Uses of Beta-Adrenergic Blocking Drugs, Excerpta Medica, Amsterdam and London.

    Google Scholar 

  • Haylett, D. G., Jenkinson, D. H.: 1972. Effects of noradrenaline on potassium efflux, membrane potential and electrolyte levels in tissue slices prepared from guinea-pig liver, J. Physiol. 225: 721–750.

    PubMed  Google Scholar 

  • Hebb, C. O., Krnjevic, K.: 1962. Neurochemistry (K. A. C. Elliot, I. H., Page, J. H. Quastel, eds.), pp. 452–521, Thomas, Springfield, 111.

    Google Scholar 

  • Hiley, C. R., Burgen, A. S. V.: 1974. The distribution of muscarinic receptor sites in the nervous system of the dog, J. Neurochem. 22: 159–162.

    Article  PubMed  Google Scholar 

  • Hiley, C. R., Young, J. M., Burgen, A. S. V.: 1972. Labelling of cholinergic receptors in subcellular fractions from rat cerebral cortex, Biochem. J. 127: 86 P.

    Google Scholar 

  • Holton, P., Ing, H. R.: 1949. Specificity of the trimethylammonium group in acetylcholine, Brit. J. Pharmacol. 4: 190–196.

    PubMed  Google Scholar 

  • Horn, A. S., Snyder, S. H.: 1971. Chlorpromazine and dopamine: Conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs, Proc. Natl. Acad. Sci. 68: 2325–2328.

    Article  PubMed  Google Scholar 

  • Horn, A. S., Cuello, A. C., Miller, R. J.: 1974. Dopamine in the mesolimbic system of the rat brain: Endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity, J. Neurochem. 22: 265–270.

    Article  PubMed  Google Scholar 

  • Hornykiewicz, O.: 1966. Dopamine and brain function, Pharmacol. Rev. 18: 925–964.

    PubMed  Google Scholar 

  • Howe, R.: 1963. Structure-activity relationships of some α-adrenergic blocking agents, Biochem. Pharmacol. Suppl. 12: 85–86.

    Article  Google Scholar 

  • Hunt, C. C., Kuffler, S. W.: 1950. Pharmacology of the neuromuscular junction, Pharmacol. Rev. 2: 96–120.

    Google Scholar 

  • Hunt, R., Renshaw, R. R.: 1925. On some effects of arsonium, stibonium, phosphonium and sulfonium compounds on the autonomic nervous system, J. Pharmacol. Exp. Ther. 25: 315–355.

    Google Scholar 

  • Hunt, R., Renshaw, R. R.: 1932. Thio and thiomethyl ammonium compounds, J. Pharmacol. Exp. Ther. 44: 151–169.

    Google Scholar 

  • Hunt, R., Renshaw, R. R.: 1933. Effects of some quaternary ammonium and analogous compounds on the autonomic nervous system, J. Pharmacol. Exp. Ther. 48: 51–66.

    Google Scholar 

  • Hunt, R., Taveau, R. de M.: 1906. On the physiological action of certain cholin derivatives and new methods for determining cholin, Brit. Med. J. 2: 1788–1791.

    Article  Google Scholar 

  • Hunt, R., Taveau, R. de M.: 1909. On the relation between the toxicity and chemical constitution of a number of derivatives of choline and analogous compounds, J. Pharmacol. Exp. Ther. 1: 303–339.

    Google Scholar 

  • Huttrer, C. P.: 1947. Chemistry of antihistamine substances, Enzymologia 12: 277–332.

    Google Scholar 

  • Idson, B.: 1950. Antihistamine drugs, Chem. Rev. 47: 307–527.

    Article  Google Scholar 

  • Ing, H. R.: 1936. The curariform action of onium salts, Physiol. Rev. 16: 527–544.

    Google Scholar 

  • Ing, H. R.: 1946. Synthetic substitutes for atropine, Brit. Med. Bull. 4: 91–95.

    PubMed  Google Scholar 

  • Ing, H. R.: 1949. The structure-action relationships of the choline group, Science 109: 264–266.

    Article  PubMed  Google Scholar 

  • Ing, H. R.: 1956. Structure-action relationships of hypotensive drugs, in: Hypotensive Drugs ( M. Harrington, ed.), pp. 7–22, Pergamon Press, Oxford.

    Google Scholar 

  • Ing, H. R., Kovdik, P., Tudor-Williams, D. P. H.: 1952. The structure-action relationships of the choline group, Brit. J. Pharmacol. 7: 103–116.

    PubMed  Google Scholar 

  • Ison, R. R., Partington, P., Roberts, G. C. K.: 1973. The conformation of catecholamines and related compounds in solution, Mol. Pharmacol. 9: 756–765.

    PubMed  Google Scholar 

  • Jacob, J., Marszak, I., Bardisa, L., Marszak-Fleury, A., Epsztein, R.: 1952. The relation of structure to activity in certain acetylcholine, ethylene and saturated derivatives of choline and acetylcholine. Arch. Int. Pharmacodyn. 91: 303–321.

    PubMed  Google Scholar 

  • Janssen, P. A. J.: 1965. The evolution of the butyrophenones, haloperidol and trifluperidol from meperidine like 4-phenylpiperidines, Int. Rev. Neurobiol. 8: 221–263.

    Article  PubMed  Google Scholar 

  • Janssen, P. A. J.: 1967. Haloperidol and related butyrophenones, in: Psychopharmacological Agents ( M. Gordon, ed.), pp. 199–248, Academic Press, New York.

    Google Scholar 

  • Janssen, P. A. J.: 1973. Structure-activity relationships (SAR) and drug design as illustrated with neuroleptic drugs, in: Structure-Activity Relationships ( C. J. Cavalitto, ed.), pp. 37–73, International Encyclopedia of Pharmacology and Therapeutics, Pergamon Press, Oxford.

    Google Scholar 

  • Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L.: 1967. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part IV, Arzneimittel-Forsch. 17: 841–854.

    Google Scholar 

  • Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., Dresse, A., Lenaerts, F. M., Pinchard, A., Schaper, W. K. A., van Nueten, J. M., Verbruggen, F. J.: 1968. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug, Arzneimittel-Forsch. 18: 261–279.

    Google Scholar 

  • Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., Lenaerts, F. M., Verbrulggen, F. J., van Nueten, J. M., Marsboom, R. H. M., Herin, V. V., Schaper, W. K. A.: 1970. The pharmacology of fluspirilene (R6218), a potent, long acting and injectable neuroleptic drug, Arzneimittel-Forsch. 20: 1689–1698.

    Google Scholar 

  • Jarrousse, M. J., Regnier, M. T.: 1951. Separation et activite physiologique des deux isomeres optiques du dimethylaminoethoxy-β-tolyphenylmethane, Ann. Pharm. Franc. 9: 321–325.

    PubMed  Google Scholar 

  • Jones, R. G.: 1966. Chemistry of histamine and analogs: Relationship between structure and pharmacological activity, in: Histamine and Anti-histamines, Part 1 (O. Eichler, A. Farah, eds.), pp. 1–43, Vol. 18 of Handbook of Experimental Pharmacology, Springer, Berlin.

    Google Scholar 

  • Kamenar, B., Prout, K., Ganellin, C. R.: 1973. Crystal and molecular structure of the histamine H2-receptor antagonist N-(4-imidazol-4-ylbutyl)-N-methyl thiourea (burimamide), J. Chem. Soc. (Perkin Trans.) 11: 1734–1739.

    Article  Google Scholar 

  • Katz, R., Heller, S. R., Jacobson, A. E.: 1973. A molecular orbital study of norepinephrine and 3,4-dihydroxyphenethylamine: A re-evolution of structure-activity relationships in norepinephrine, Mol. Pharmacol. 9: 486–494.

    PubMed  Google Scholar 

  • Kebabian, J. W., Petzold, G. L., Greengard, P.: 1972. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain and its similarity to the “dopamine receptor,” Proc. Natl. Acad. Sci. 69: 2145–2149.

    Article  PubMed  Google Scholar 

  • Kerkut, G. A.: 1973. Catecholamines in invertebrates, Brit. Med. Bull. 29: 100–104.

    PubMed  Google Scholar 

  • Kerkut, G. A., Walker, R. J.: 1961. The effects of drugs on the neurones of the snail, Helix aspersa, Comp. Biochem. Physiol. 3: 143–160.

    Google Scholar 

  • Kier, L. B.: 1967. Molecular orbital calculation of preferred conformations of acetylcholine, muscarine and muscarone, Mol. Pharmacol. 3: 487–494.

    PubMed  Google Scholar 

  • Kier, L. B.: 1968a. Preferred conformation of serotonin and a postulate on the nature of its receptor from molecular orbital calculations, J. Pharm. Sci. 57: 1188–1191.

    Article  PubMed  Google Scholar 

  • Kier, L. B.: 1968b. Molecular orbital calculations of the preferred conformations of histamine and a theory on its dual activity, J. Med. Chem. 11: 441–445.

    Article  PubMed  Google Scholar 

  • Klein, D. F., Davis, J. M.: 1969. Diagnosis and Treatment of Psychiatric Disorders, Williams and Wilkins, Baltimore.

    Google Scholar 

  • Koch, M. H. J.: 1973. 4-(4-Chloro-a, a, a-trifluoro-m-tolyl)-l-[4,4-bis-(-fluorophenyl)butyl]-4- piperidinol (penfluridol), Acta Crystallog. B29: 1538–1540.

    Google Scholar 

  • Koch, M. H. J., Germain, G.: 1972. The crystal and molecular structure of 4’-fluoro-4-(1- [4-hydroxy-4-(4’-fluoro)-phenylpiperidinol])butyrophenone and its hydrochloride, Acta Crystallog. B28: 121–125.

    Article  Google Scholar 

  • Korolkovas, A.: 1970. In: Essentials of Molecular Pharmacology: Background for Drug Design, Wiley, New York.

    Google Scholar 

  • Koshland, D. E.: 1958. Application of a theory of enzyme specificity to protein synthesis, Proc. Natl. Acad. Sci. 44: 98–104.

    Article  PubMed  Google Scholar 

  • Kvam, D. C., Riggilo, D. A., Lish, P. M.: 1965. Effect of some new α-adrenergic blocking agents on certain metabolic responses to catecholamines, J. Pharmacol. Exp. Ther. 149: 183–192.

    PubMed  Google Scholar 

  • Lal, S., Sourkes, T. L.: 1972. Effects of various chlorpromazine metabolites on amphetamine induced stereotyped behaviour in the rat, Eur. J. Pharmacol. 17: 283–286.

    Article  PubMed  Google Scholar 

  • Lands, A. M.: 1951. An investigation of the molecular configurations favorable for stimulation or blockade of the acetylcholine-sensitive receptors of visceral organs, J. Pharmacol. Exp. Ther. 102: 219–236.

    PubMed  Google Scholar 

  • Lands, A.M.: 1952a. The cardiovascular actions of l-β-aminophenyl)-2-aminoethanol and related compounds, J. Pharmacol. Exp. Ther. 104: 474–477.

    PubMed  Google Scholar 

  • Lands, A. M.: 1952b. The effect on blood pressure and toxicity of l-β-fluorophenyl)-2- aminoethanol and related compounds, J. Pharmacol. Exp. Ther. 106: 440–443.

    PubMed  Google Scholar 

  • Lands, A. M., Brown, T. G.: 1967. Sympathomimetic (adrenergic) stimulants, in: Drugs Affecting the Peripheral Nervous System ( A. Burger, ed.), pp. 399–472, Dekker, New York.

    Google Scholar 

  • Lands, A. M., Cavallito, C. J.: 1954. An evaluation of the factors favorable for acetylcholine like stimulation by employing a series of quaternary ammonium alkyl sulfide and sulfoxide compounds, J. Pharmacol. Exp. Ther. 110: 369–384.

    PubMed  Google Scholar 

  • Lands, A. M., Grant, J. I.: 1952. The vasopressor action and toxicity of cyclohexylethylamine derivatives, J. Pharmacol. Exp. Ther. 106: 341–345.

    PubMed  Google Scholar 

  • Lands, A. M., Luduena, F. P.: 1956. The cholinolytic action of substituted dialkylaminoalkanes and dialkylaminoalkanols, J. Pharmacol. Exp. Ther. 116: 177–190.

    PubMed  Google Scholar 

  • Lands, A. M., Tainter, M. I.: 1953. The effect of changes in molecular configuration on inhibitory sympathomimetic action, Arch. Exp. Pathol. Pharmakol. 219: 76–96.

    Google Scholar 

  • Lands, A. M., Nash, V. L., Mccarthy, H. M., Granger, H. R., Dertinger, B. L.: 1947a. The pharmacology of N-alkyl homologues of epinephrine, J. Pharmacol. Exp. Ther. 90: 110–119.

    PubMed  Google Scholar 

  • Lands, A. M., Nash, V. L., Granger, H. R., Dertinger, B. L.: 1947b. The pharmacologic activity of N-methyl-ß-cyclohexyl-isopropylamine HC1, J. Pharmacol. Exp. Ther. 89: 383–385.

    Google Scholar 

  • Lands, A. M., Nash, V. L., Dertinger, B. L., Granger, H. R., Mccarthy, H. M.: 1948. The pharmacology of compounds structurally related to hydroxytryptamine, J. Pharmacol. Exp. Ther. 92: 369–380.

    PubMed  Google Scholar 

  • Langer, S. Z., Rubio, M. C.: 1973. Effects of the noradrenaline metabolites on the adrenergic receptors, Naunyn Schmiedebergs Arch. Pharmakol. 276: 71–88.

    Article  Google Scholar 

  • Larsen, A. A., Gould, W. A., Roth, H. R., Comer, W. T., Uloth, R. H., Dungan, K. W., Lish, P. M.: 1967. Sulfonanilides. II. Analogs of Catecholamines, J. Med. chem. 10: 462–472.

    Article  PubMed  Google Scholar 

  • Laverty, R., Sharman, D. H.: 1965. Modification by drugs of the metabolism of 3,4-dihydroxy phenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain, Brit. J. Pharmacol. 24: 759–772.

    PubMed  Google Scholar 

  • Lehmann, G., Randall, L. O.: 1948. Pharmacological properties of sympathomimetic diamines, J. Pharmacol. Exp. Ther. 93: 115–125.

    Google Scholar 

  • Leonard, F., Huttrer, C. P.: 1956. Histamine Antagonists, Chemical Biological Coordination Center, National Research Council, Washington, D.C.

    Google Scholar 

  • Lewis, J. J., Muir, T. C.: 1967. Drugs acting at nerve-skeletal muscle junctions, in: Drugs Affecting the Peripheral Nervous System (A. Burger, ed.), pp. 327–364, Dekker, New York.

    Google Scholar 

  • Liquori, A. M., Damiani, A., Elefante, G.: 1968a. Calculated minimum energy conformations of muscarine, J. Mol. Biol. 33: 439–444.

    Article  PubMed  Google Scholar 

  • Liqouri, A. M., Damiani, A., Decoen, J. L.: 1968b. Calculated minimum energy conformations of acetylcholine, J. Mol. Biol. 33: 445–450.

    Article  Google Scholar 

  • Loew, E. R.: 1947. Pharmacology of antihistamine compounds, Physiol. Rev. 27: 542–573.

    PubMed  Google Scholar 

  • Loewi, O.: 1921. Uber humor ale Ubertragbarkeit der Herznervenwirkung. I. Milleilung, Pfluegers Arch. Ges. Physiol. 189: 239–242.

    Article  Google Scholar 

  • Marsh, D. F., Howard, A., Herring, D. A.: 1951. The comparative pharmacology of the isomeric nitrogen methyl substituted heptylamines, J. Pharmacol. Exp. Ther. 103: 325–329.

    PubMed  Google Scholar 

  • Marszak, I., Olomucki, M., Epsztein, R., Jacob, J.: 1954. Unsaturated amines. IX. Synthesis and parasympathomimetic properties of ethylenic quaternary ammonium salts, Comp. Rend. Acad. Sci. Paris 238: 166–168.

    Google Scholar 

  • Matthysse, S.: 1973. Antipsychotic drug actions: A clue to the neuropathology of schizophrenia? Fed. Proc. 32: 200–205.

    PubMed  Google Scholar 

  • Mayer, S. E., Stull, J. T.: 1971. Cyclic AMP in Skeletal Muscle, Ann. N.Y. Acad. Sci. 185: 433–448.

    Article  PubMed  Google Scholar 

  • Mcdowell, J. J. H.: 1969. The crystal and molecular structure of chlorpromazine, Acta Crystallog. B25: 2175–2181.

    Article  Google Scholar 

  • Mcgeer, E. G., Mcgeer, P. L., Mclennan, H.: 1961. The inhibitory action of δ-hydroxytryptamine, gamma-aminobutyric acid (GABA) and some other compounds towards the crayfish stretch receptor neuron, J. Neurochem. 8: 36–49.

    Article  Google Scholar 

  • Mcisaac, W. M., Page, I. H.: 1958. New metabolites of serotonin in carcinoid urine, Science 128: 537.

    Article  PubMed  Google Scholar 

  • Mcnay, J. L., Mcdonald, R. H., Goldberg, L. I.: 1965. Direct renal vasodilation produced by dopamine in the dog, Circ. Res. 16: 510–517.

    PubMed  Google Scholar 

  • Melville, K. I.: 1973. Antihistamine drugs, in: Histamine and Antihistamines ( M. Schachter, ed.), pp. 127–171, International Encyclopedia of Pharmacology and Therapeutics, Pergamon Press, Oxford.

    Google Scholar 

  • Miller, R. J., Hiley, C. R.: 1974. Relation of anti-muscarinic properties of neuroleptics to drug induced parkinsonism, Nature 248: 596–597.

    Article  PubMed  Google Scholar 

  • Miller, R. J., Iversen, L. L.: 1974. Effect of psychoactive drugs on dopamine (3,4- dihydroxyphenethylamine)-sensitive adenylate cyclase activity in corpus striatum of rat brain, Biochem. Soc. Trans. 1: 90–93.

    Google Scholar 

  • Moe, G. K., Freyburger, W. A.: 1950. Ganglionic Blocking Agents, Pharmacol. Rev. 2: 61–95.

    Google Scholar 

  • Moller-Nielsen, I., Hougs, W., Lassen, N., Holm, T., Petersen, P. V.: 1962. Central Depressant Activity of Some Thiaxanthene Derivatives, Acta Pharmacol. Toxicol. 19: 87–100.

    Article  Google Scholar 

  • Moller-Nielsen, I., Pedersen, V., Nymark, M., Franck, K. F., Boeck, V., Fjallan, B., Christensen, A. V.: 1973. The Comparative Pharmacology of Flupenthixol and Some Reference Neuroleptics, Acta Pharmacol. Toxicol. 33: 353–362.

    Article  Google Scholar 

  • Nachod, F. C., Lands, A. M.: 1953. Relationship between chemical structure and biological activity of compounds with atropine-like activity, Trans. N.Y. Acad. Sci. 16: 2–13.

    Article  PubMed  Google Scholar 

  • Nauta, W. T., Rekker, R. F., Harms, A. F.: 1968. Diarylcarbinolethers: Structure-activity relationships. A physico-chemical approach, in: Proceedings of the Third International Pharmacology Meeting, Vol. 7, pp. 305–325, Pergamon Press, New York.

    Google Scholar 

  • Nogradi, M., Ollis, W. D., Sutherland, I. D.: 1970. The conformational inversion of 2,3:6,7-dibenzo-derivatives of cycloheptatriene, tropone, heptafulvene, oxepin, thiepin and azepin, Chem. Commun. 1970: 158–160.

    Google Scholar 

  • Nyback, H.: 1971. Regional disappearance of catecholamines formed from 14C-tyrosine in rat brain: Effect of synthesis inhibitors and of chlorpromazine, Acta Pharmacol. Toxicol. 30: 372–384.

    Article  Google Scholar 

  • Nyback, H., Sedvall, G.: 1968. Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain, J. Pharmacol. Exp. Ther. 162: 294–301.

    PubMed  Google Scholar 

  • Nyback, H., Sedvall, G.: 1972. Effect of chlorpromazine and some of its metabolites on synthesis and turnover of catecholamines formed from I4C-tyrosine in mouse brain, Psychopharmacologia 26: 155–160.

    Article  PubMed  Google Scholar 

  • Osborne, M., Detar, R., Gabel, L.: 1962. Comparison between the autonomic pharmacology of 5-hydroxytryptamine and 5-acetyltryptamine (5-AT), Fed. Proc. 21: 324.

    Google Scholar 

  • Paton, W. D. M., Zaimis, E. J.: 1952. The methonium compounds, Pharmacol. Rev. 4: 219–253.

    PubMed  Google Scholar 

  • Pauling, P., Petcher, T. J.: 1973. Neuromuscular blocking agents: Structures and activity, Chem. Biol. Interact. 6: 351–365.

    Article  PubMed  Google Scholar 

  • Pederson, L., Hoskins, R. E., Cable, H.: 1971. The preferred conformation of noradrenaline, J. Pharm. Pharmacol. 23: 216–218.

    Article  Google Scholar 

  • Periti, P. F.: 1970. On active conformation of histamine and analogues, Pharmacol. Res. Commun. 2: 309–318.

    Article  Google Scholar 

  • Petersen, P. V., Moller-Nielsen, I.: 1964. Thioxanthene derivatives, in: Psychopharmacological Agents, Vol. 1 ( M. Gordon, ed.), pp. 301–324, Academic Press, New York.

    Google Scholar 

  • Phillis, J. W., Tebecis, A. K.: 1967. The responses of thalamic neurones to iontophoretically applied monoamines, J. Physiol. 192: 715–745.

    PubMed  Google Scholar 

  • Post, M. L., Kennard, O., Horn, A. S.: 1974. 2-Chloro-9-(w-dimethyl- aminopropylidene)thioxanthene, Acta Crystallog B30: 1644–1646.

    Google Scholar 

  • Powell, C. E., Slater, I. H.: 1958. Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol, J. Pharmacol. Exp. Ther. 122: 480–488.

    PubMed  Google Scholar 

  • Pratesi, P., La Manna, A., Campiglio, A., Ghislandi, V.: 1958. The configuration of adrenaline and of its β-hydroxyphenyl analogue, J. Chem. Soc. 1958: 2069–2074.

    Article  Google Scholar 

  • Pratesi, P., La Manna, A., Campiglio, A., Ghislandi, V.: 1959. The configuration of Noradrenaline, J. Chem. Soc. 1959: 4062–4065.

    Article  Google Scholar 

  • Pullman, B., Courriere, P., Coubeils, J. L.: 1971. Quantum mechanical study of the conformational and electronic properties of acetylcholine and its agonists muscarine and nicotine, Mol. Pharmacol. 7: 397–405.

    PubMed  Google Scholar 

  • Pullman, B., Coubeils, J. L., Courriere, P., Gervois, J. P.: 1972. Quantum mechanical study of the conformation properties of phenethylamines of biochemical and medical interest, J. Med. Chem. 15: 17–23.

    Article  PubMed  Google Scholar 

  • Randrup, A., Munkvad, I.: 1970. Biochemical anatomical and psychological investigations of stereotyped behavior induced by amphetamines, in: Amphetamines and Related Compounds ( E. Costa, S. Garattini, eds.), pp. 695–713, Raven Press, New York.

    Google Scholar 

  • Randrup, A., Scheel-Kruger, J.: 1966. Diethyldithiocarbamate and amphetamine stereotype behaviour, J. Pharm. Pharmacol. 18: 752.

    Article  PubMed  Google Scholar 

  • Randrup, A., Munkvad, I., Udsen, P.: 1963. Adrenergic mechanisms and amphetamine induced abnormal behaviour, Acta Pharmacol. Toxicol. 20: 145–157.

    Article  Google Scholar 

  • Reed, L. L., Schaefer, J. P.: 1973. The crystal and molecular structure of haloperidol, a potent psychotropic drug, Acta Crystallog. 829: 1886–1890.

    Google Scholar 

  • Renshaw, R. R., Hopkins, C. T.: 1929. Phosphoric acid ester derivatives of choline: Basis for the psychological activity of -onium compounds, J. Am. Chem. Soc. 51: 953–964.

    Article  Google Scholar 

  • Renshaw, R. R., Hunt, R.: 1929. The pharmacological action of some homologues of betaine and choline esters, J. Pharmacol. Exp. Ther. 37: 309–337.

    Google Scholar 

  • Renshaw, R. R., Dreisbach, P. F., Ziff, M., Green, D.: 1938. Thioesters of choline and O-methylcholine and their psychological activity: Onium compounds, J. Am. Chem. Soc. 60: 1765–1770.

    Article  Google Scholar 

  • Robison, G. A., Butcher, R. W., Sutherland, E. W.: 1967. Adenylcyclase as an adrenergic receptor, Ann. N.Y. Acad. Sci. 139: 703–723.

    Article  PubMed  Google Scholar 

  • Robison, G. A., Butcher, R. W., Sutherland, E. W.: 1971. Cyclic AMP, p. 225, Academic Press, New York.

    Google Scholar 

  • Rocha, E., Silva, M.: 1960. Influence of pH on the interaction of histamine with its receptors in the guinea pig ileum, Arch. Int. Pharmacodyn. 128: 355–374.

    Google Scholar 

  • Saavedra, J. M., Brownstein, M., Axelrod, J.: 1973. A specific and sensitive enzymaticisotopic microassay for serotonin in tissues, J. Pharmacol. Exp. Ther. 186: 508–515.

    PubMed  Google Scholar 

  • Salle, J.: 1952. The pharmacology of fluroacetylcholine bromide, Arch. Int. Pharmacodyn. 91: 339–349.

    PubMed  Google Scholar 

  • Sastry, B. V. R., Pfeiffer, C. C., Lasslo, A.: 1960. Relation between chemical constitution and biological response of D(—), L(+) and DL-lactoylcholines and related compounds, J. Pharmacol. Exp. Ther. 130: 346–355.

    PubMed  Google Scholar 

  • Schaefer, J. P.: 1967. The structure of thiothixene, Chem. Commun. 1967: 743–744.

    Google Scholar 

  • Scheel-Kruger, J.: 1972. Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic antidepressant drugs, Eur. J. Pharmacol. 18: 63–73.

    Article  PubMed  Google Scholar 

  • Schmiedeberg, O., Koppe, R.: 1869. Das Muscarine, das Giftige Alkaloid des Fliegenpilzes, Vogel, Leipzig.

    Google Scholar 

  • Schueler, F. W.: 1953. The statistical nature of the intramolecular distance factor of the muscarinic moiety, Arch. Int. Pharmacodyn. 93: 417–426.

    PubMed  Google Scholar 

  • Schueler, F. W., Hanna, C.: 1951. The pharmacological activities of some hydrazonium analogs related to acetylcholine tetramethylammonium and tetraethylammonium, Arch. Int. Pharmacodyn. 88: 351–360.

    Google Scholar 

  • Schueler, F. W., Keasling, H. H.: 1951. Further studies on the RC (reversed carboxyl) analog of acetylcholine and some additional derivatives, J. Pharmacol. Exp. Ther. 103: 222–235.

    PubMed  Google Scholar 

  • Scott, K. A., Mautner, H. G.: 1967. Sulfur and selenium isologs related to acetylcholine and choline-IX, Biochem. Pharmacol. 16: 1903–1918.

    Article  PubMed  Google Scholar 

  • Shader, R. I., Dimascio, A.: 1970. Psychotropic Drug Side Effects, Williams and Wilkins, Baltimore.

    Google Scholar 

  • Shefter, E., Triggle, D. T.: 1970. Is there a unique conformation of cholinergic ligands responsible for muscarinic activity? Nature 227: 1354–1355.

    Article  PubMed  Google Scholar 

  • Sheppard, H., Burghardt, C., Greengard, P.: 1973. The interaction of dopamine and its derivatives with the dopamine-sensitive adenylate cyclase of rat caudate nucleus, Pharmacologist 15: 231.

    Google Scholar 

  • Simonart, A.: 1932, On the action of certain derivatives of choline, J. Pharmacol. Exp. Ther. 46: 157–193.

    Google Scholar 

  • Simonart, A.: 1934. Contribution a l’etude des? alkyl cholines, Arch. Int. Pharmacodyn. 48: 328–332.

    Google Scholar 

  • Simpson, T. R. Jr., Craig, J. C., Kumler, W. D.: 1967. Determination of the conformation of nicotine and some related compounds by nuclear magnetic resonance and dipole moments, J. Pharm. Sci. 56: 708–713.

    Article  PubMed  Google Scholar 

  • Singhgrewal, R.: 1952. The pharmacological actions of 6-methyladrenaline, Brit. J. Pharmacol. 7: 338–348.

    Google Scholar 

  • Snyder, S. H.: 1972. Catecholamines in the brain as mediators of amphetamine psychosis, Arch. Gen. Psychiat. 27: 169–179.

    Article  PubMed  Google Scholar 

  • Snyder, S. H., Greenberg, D., Yamamura, H. I.: 1974. Antischizophrenicdrugsandbrain cholinergic receptors: Affinity for muscarinic sites predicts extrapyramidal effects, Arch. Gen. Psychiat., 31: 58–61.

    Article  PubMed  Google Scholar 

  • Soudijn, W., van Wijngaarden, I.: 1972. Localization of 3H-pimozide in the rat brain in relation to its anti-amphetamine potency, J. Pharm. Pharmacol. 24: 773–780.

    Article  PubMed  Google Scholar 

  • Stehle, R. L., Melville, K. I., Oldham, F. K.: 1936. Choline as a factor in the elaboration of adrenaline, J. Pharmacol. Exp. Ther. 56: 473–481.

    Google Scholar 

  • Stenlake, J. B.: 1963. Some chemical aspects of neuromuscular block, in: Progress in Medicinal Chemistry, Vol. 3 ( G. P. Ellis, G. B. West, eds.), pp. 1–51, Butterworth, London.

    Google Scholar 

  • Stoll, H. C.: 1948. Pharmacodynamic considerations of atropine and related compounds, Am. J. Med. Sci. 215: 577–592.

    PubMed  Google Scholar 

  • Swanson, E. E., Chen, K. K.: 1946. Comparison of pressor action of aliphatic amines, J. Pharmacol. Exp. Ther. 88: 10–13.

    PubMed  Google Scholar 

  • Swanson, E. E., Steldt, F. A., Chen, K. K.: 1945. Further observations on the pressor action of optical isomers of sympathomimetic amines, J. Pharmacol. Exp. Ther. 85: 70–73.

    PubMed  Google Scholar 

  • Taylor, D. B., Nederguard, O. A.: 1965. Relation between structure and action of quaternary ammonium neuromuscular blocking agents, Physiol. Rev. 45: 523–554.

    PubMed  Google Scholar 

  • Testa, B., Jenner, P.: 1973. Circular dichroic determination of the preferred conformation of nicotine and related chiral alkaloids in aqueous solution, Mol. Pharmacol. 9: 10–16.

    PubMed  Google Scholar 

  • Trendelenburg, U.: 1956. The action of 5-hydroxytryptamine on the nictitating membrane and on the superior cervical ganglion of the cat, Brit. J. Pharmacol. 11: 74–80.

    PubMed  Google Scholar 

  • Trendelenburg, U.: 1957. The action of morphine on the superior cervical ganglion and on the nictitating membrane of the cat, Brit. J. Pharmacol. 12: 79–85.

    PubMed  Google Scholar 

  • Trendelenburg, U., Muskus, A., Fleming, W. W., Alonso, S. B. G.: 1962. Modification by reserpine of the action of sympathomimetic amines in spinal cats; a classification of sympathomimetic amines, J. Pharmacol. Exp. Ther. 138: 170–180.

    PubMed  Google Scholar 

  • Triggle, D. J.: 1970. Adrenergic hormones and drugs, in: Medicinal Chemistry, Vol. II ( A. Burger, ed.), pp. 1235–1295, Wiley-Interscience, New York.

    Google Scholar 

  • Triggle, D. J.: 1971. Neurotransmitter-Receptor Interactions, Academic Press, London.

    Google Scholar 

  • Triggle, D. J.: 1972. Adrenergic receptors, Ann. Rev. Pharmacol. 12: 185–196.

    Article  PubMed  Google Scholar 

  • Turtle, J. R., Kipnis, D. M.: 1967. An adrenergic receptor mechanism for the control of cyclic 3’,5’-adenosine monophosphate systems in tissue, Biochem. Biophys. Res. Commun. 28: 797–802.

    Article  PubMed  Google Scholar 

  • Ungerstedt, U.: 1971. Stereotaxic mapping of the monoamine pathways in the rat brain, Acta Physiol. Scand. Suppl. 376: 1–48.

    Google Scholar 

  • Urech, E., Marxer, A., Miescher, K.: 1950. Aminoalkyl-imidazoline, Helv. Chim. Acta 33: 1386–1407.

    Article  Google Scholar 

  • Vane, J. R.: 1957. A sensitive method for the assay of 5-hydroxytryptamine, Brit. J. Pharmacol. 12: 344–349.

    PubMed  Google Scholar 

  • Vane, J. R.: 1959. The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation, Brit. J. Pharmacol. 14: 87–98.

    PubMed  Google Scholar 

  • van Rossum, J. M.: 1962. Pharmacodynamics of parasympathetic drugs: Mechanism of action and structure action of tertiary ammonium salts, Arch. Int. Pharmacodyn. 140: 592–605.

    PubMed  Google Scholar 

  • van Rossum, J. M., Ariens, E. J.: 1959. Pharmacodynamics of parasympathetic drugs: Structure-action relations in homologous series of quaternary ammonium salts, Arch. Int. Pharmacodyn. 118: 418–446.

    Google Scholar 

  • Waser, P. G.: 1961. Chemistry and pharmacology of muscarine, muscarone and some related compounds, Pharmacol. Rev. 13: 465–515.

    PubMed  Google Scholar 

  • Weissman, A., Koe, K. B., Tenen, S. S.: 1966. Antiamphetamine effects following inhibition of tyrosine hydroxylase, J. Pharmacol. Exp. Ther. 151: 339–352.

    PubMed  Google Scholar 

  • Welch, A. D., Roepke, M. H.: 1935. A comparative study of choline and certain of its analogues, J. Pharmacol. Exp. Ther. 55: 118–126.

    Google Scholar 

  • Welsh, J. H., Taub, R.: 1951. The significance of the carbonyl group and ether oxygen in the reaction of Ach with receptor substance, J. Pharmacol. Exp. Ther. 103: 62–73.

    PubMed  Google Scholar 

  • Werner, L. H., Barrett, W. E.: 1967. In: Antihypertensive Agents (E. Schlittler, ed.), pp. 331–392, Academic Press, New York.

    Google Scholar 

  • Whittaker, V. P.: 1963. In: Handbook of Experimental Pharmacology, Vol. 15 (G. B. Koelle, ed.), pp. 1–39, Springer, Berlin.

    Google Scholar 

  • Wilkinson, S.: 1961. The history and chemistry of muscarine, Quart. Rev. Chem. Soc. 15: 153–171.

    Article  Google Scholar 

  • Woodruff, G. N.: 1971. Dopamine Receptors: A review, Comp. Gen. Pharmacol. 2: 439–455.

    Article  PubMed  Google Scholar 

  • Woodruff, G. N., Walker, R. J.: 1969. The effect of dopamine and other compounds on the activity of neurones of Helix aspersa: Structure-activity relationships, Int. J. Neuropharmacol. 8: 279–289.

    Article  PubMed  Google Scholar 

  • Woolley, D. W.: 1959. Highly potent antimetabolites of serotonin with litde serotonin-like action, Biochem. Pharmacol. 1: 51–59.

    Article  Google Scholar 

  • Woolley, D. W., Campbell, N. K.: 1962. Serotonin-like and antiserotonin properties of psilocybin and psilocin, Science 136: 777–779.

    Article  PubMed  Google Scholar 

  • Wurzel, M.: 1959. A suggested mechanism for the action of choline esters on animal organs, inferred from a study of the effects of choline, J-methylcholine and thiocholine-esters, Experientia 15: 430–433.

    Article  Google Scholar 

  • Yamamoto, C.: 1967. Pharmacologic studies of norepinephrine, acetylcholine and related compounds on neurons in Deiters’ nucleus and the cerebellum, J. Pharmacol. Exp. Ther. 156: 39–47.

    PubMed  Google Scholar 

  • Yamamura, H. I., Snyder, S. H.: 1974. Muscarinic cholinergic receptor binding in rat brain, Prox. Natl. Acad. Sci., 71: 1725–1729.

    Article  Google Scholar 

  • Yeh, B. K., Mcnay, J. L., Goldberg, L. I.: 1969. Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: Evidence of a specific dopamine receptor, J. Pharmacol. Exp. Ther. 168: 303–309.

    PubMed  Google Scholar 

  • Zirkle, C. L., Kaiser, C.: 1970. Antipsychotic agents, in: Medicinal Chemistry, Vol. 11 (A. Burger, ed.), pp. 1410–1469, Wiley-InterScience, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Plenum Press, New York

About this chapter

Cite this chapter

Horn, A.S. (1975). Structure-Activity Relations for Neurotransmitter Receptor Agonists and Antagonists. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds) Principles of Receptor Research. Handbook of Psychopharmacology, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3168-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3168-1_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3170-4

  • Online ISBN: 978-1-4684-3168-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics